• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.PD-1 信号在 CD4(+) T 细胞中抑制其对免疫原性刺激的克隆扩增,但对于肽诱导的耐受并非关键必需。
Immunology. 2010 May;130(1):92-102. doi: 10.1111/j.1365-2567.2009.03216.x. Epub 2010 Jan 27.
2
Programmed death-1 (PD-1):PD-ligand 1 interactions inhibit TCR-mediated positive selection of thymocytes.程序性死亡蛋白1(PD-1):PD-配体1的相互作用抑制T细胞受体介导的胸腺细胞阳性选择。
J Immunol. 2005 Dec 1;175(11):7372-9. doi: 10.4049/jimmunol.175.11.7372.
3
Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.体内CD4和CD8 T细胞介导的同种异体免疫反应中负性T细胞共刺激途径的作用分析
J Immunol. 2005 Jun 1;174(11):6648-56. doi: 10.4049/jimmunol.174.11.6648.
4
Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.程序性死亡受体-1配体/程序性死亡受体-1信号通路对树突状细胞介导的CD4+ T细胞活化的作用
Eur J Immunol. 2006 Sep;36(9):2472-82. doi: 10.1002/eji.200635978.
5
Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression.肌肉特异性抗原表达诱导的CD8 + T细胞功能耐受
J Immunol. 2008 Jul 1;181(1):408-17. doi: 10.4049/jimmunol.181.1.408.
6
LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.Lag-3、TGF-β 和细胞内 PD-1 抑制途径有助于异基因 BMT 联合抗 CD40L 诱导的 CD8 而非 CD4 T 细胞耐受。
Blood. 2011 May 19;117(20):5532-40. doi: 10.1182/blood-2010-11-318675. Epub 2011 Mar 21.
7
CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.CD8+ 树突状细胞介导的自身反应性 CD4+ T 细胞耐受在 NOD 小鼠中缺陷,并可通过阻断 CD40L 来纠正。
J Leukoc Biol. 2014 Feb;95(2):325-36. doi: 10.1189/jlb.0113013. Epub 2013 Sep 30.
8
CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism.细胞毒性T淋巴细胞相关蛋白4(CTLA-4)阻断通过一种依赖于辅助性T细胞(CD4+ T细胞)和白细胞介素-2(IL-2)的机制逆转CD8+ T细胞对肿瘤的耐受性。
Immunity. 1999 Oct;11(4):483-93. doi: 10.1016/s1074-7613(00)80123-5.
9
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.在稳态下,将蛋白质抗原有效靶向树突状细胞受体DEC-205可导致抗原在主要组织相容性复合体I类产物上呈递,并诱导外周CD8+ T细胞产生耐受性。
J Exp Med. 2002 Dec 16;196(12):1627-38. doi: 10.1084/jem.20021598.
10
Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4 and CD8 T Cells.载抗原的 PLG 纳米颗粒诱导的耐受会影响转基因 CD4 和 CD8 T 细胞的表型和归巢。
Cells. 2021 Dec 7;10(12):3445. doi: 10.3390/cells10123445.

引用本文的文献

1
Distinct immune profiles in children living with HIV based on timing and duration of suppressive antiretroviral treatment.基于抑制性抗逆转录病毒治疗的时间和持续时间,感染艾滋病毒儿童的不同免疫特征。
Virology. 2025 Jan;602:110318. doi: 10.1016/j.virol.2024.110318. Epub 2024 Nov 26.
2
Dynamic immune signatures of patients with advanced non-small-cell lung cancer for infection prediction after immunotherapy.免疫治疗后预测晚期非小细胞肺癌患者感染的动态免疫特征。
Front Immunol. 2024 Jan 26;15:1269253. doi: 10.3389/fimmu.2024.1269253. eCollection 2024.
3
Immunological Misfiring and Sex Differences/Similarities in Early COVID-19 Studies: Missed Opportunities of Making a Real IMPACT.免疫失调与 COVID-19 早期研究中的性别差异/相似性:错失产生真正影响的机会。
Cells. 2023 Nov 8;12(22):2591. doi: 10.3390/cells12222591.
4
Large extracellular vesicles derived from human regulatory macrophages (L-EV) attenuate CD3/CD28-induced T-cell activation in vitro.来源于人调节性巨噬细胞的大型细胞外囊泡(L-EV)可减轻体外 CD3/CD28 诱导的 T 细胞活化。
J Mol Med (Berl). 2023 Nov;101(11):1437-1448. doi: 10.1007/s00109-023-02374-9. Epub 2023 Sep 19.
5
Circadian rhythm-related factors of PER and CRY family genes function as novel therapeutic targets and prognostic biomarkers in lung adenocarcinoma.昼夜节律相关因素的 PER 和 CRY 家族基因可作为肺腺癌的新型治疗靶点和预后生物标志物。
Aging (Albany NY). 2022 Nov 16;14(22):9056-9089. doi: 10.18632/aging.204386.
6
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.癌症患者感染 SARS-CoV-2 后(包括感染关注变异株)的功能性抗体和 T 细胞免疫:CAPTURE 研究。
Nat Cancer. 2021 Dec;2(12):1321-1337. doi: 10.1038/s43018-021-00275-9. Epub 2021 Oct 27.
7
A Novel Renoprotective Strategy: Upregulation of PD-L1 Mitigates Cisplatin-Induced Acute Kidney Injury.一种新的肾保护策略:上调 PD-L1 减轻顺铂诱导的急性肾损伤。
Int J Mol Sci. 2021 Dec 10;22(24):13304. doi: 10.3390/ijms222413304.
8
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.癌症患者感染新型冠状病毒2(SARS-CoV-2)包括受关注变异株后的功能性抗体和T细胞免疫:CAPTURE研究
Res Sq. 2021 Sep 20:rs.3.rs-916427. doi: 10.21203/rs.3.rs-916427/v1.
9
Immune checkpoint inhibitor-associated celiac disease.免疫检查点抑制剂相关的乳糜泻。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000958.
10
Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints.肿瘤微环境对树突状细胞和T细胞功能的影响:聚焦于临床相关的免疫和代谢检查点。
Clin Transl Med. 2020 Jan;10(1):374-411. doi: 10.1002/ctm2.37.

本文引用的文献

1
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.程序性死亡受体1(PD-1)与程序性死亡配体1(PD-L1)之间的相互作用通过阻断T细胞受体(TCR)诱导的终止信号来促进免疫耐受。
Nat Immunol. 2009 Nov;10(11):1185-92. doi: 10.1038/ni.1790. Epub 2009 Sep 27.
2
PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo.PD-1介导的白细胞介素-2产生抑制在体内诱导CD8 + T细胞无反应性。
J Immunol. 2009 Jun 1;182(11):6682-9. doi: 10.4049/jimmunol.0900080.
3
Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1.无助记忆性CD8+ T细胞的回忆反应受程序性死亡受体1(PD-1)上调的限制。
J Immunol. 2009 Apr 1;182(7):4244-54. doi: 10.4049/jimmunol.0802041.
4
Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.在阻断PD-1配体后,肠道耐受性转变为自身免疫性肠炎。
J Immunol. 2009 Feb 15;182(4):2102-12. doi: 10.4049/jimmunol.0802769.
5
Tolerance without clonal expansion: self-antigen-expressing B cells program self-reactive T cells for future deletion.无克隆扩增的耐受性:表达自身抗原的B细胞对自身反应性T细胞进行编程,使其在未来被清除。
J Immunol. 2008 Oct 15;181(8):5748-59. doi: 10.4049/jimmunol.181.8.5748.
6
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.通过CTLA-4和PD-1途径控制外周T细胞耐受性和自身免疫
Immunol Rev. 2008 Aug;224:166-82. doi: 10.1111/j.1600-065X.2008.00662.x.
7
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.同种异体反应性CD8而非CD4 T细胞的外周删除性耐受依赖于PD-1/PD-L1途径。
Blood. 2008 Sep 1;112(5):2149-55. doi: 10.1182/blood-2007-12-127449. Epub 2008 Jun 24.
8
PD-1 and its ligands in tolerance and immunity.PD-1及其配体在免疫耐受与免疫中的作用
Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331.
9
PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.程序性死亡受体1(PD-1)调节淋巴结和组织中自身反应性CD8 + T细胞对抗原的反应。
J Immunol. 2007 Oct 15;179(8):5064-70. doi: 10.4049/jimmunol.179.8.5064.
10
Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.程序性细胞死亡蛋白1(PD-1)及其配体PD-L1是同种异体移植耐受所必需的。
Eur J Immunol. 2007 Oct;37(10):2983-90. doi: 10.1002/eji.200737583.

PD-1 信号在 CD4(+) T 细胞中抑制其对免疫原性刺激的克隆扩增,但对于肽诱导的耐受并非关键必需。

PD-1 signalling in CD4(+) T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance.

机构信息

Centre for Immunity Infection and Evolution, Institute of Immunology and Infection Research, Ashworth Laboratories, School of Biological Sciences, University of Edinburgh, Edinburgh, UK.

出版信息

Immunology. 2010 May;130(1):92-102. doi: 10.1111/j.1365-2567.2009.03216.x. Epub 2010 Jan 27.

DOI:10.1111/j.1365-2567.2009.03216.x
PMID:20113370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2855797/
Abstract

The ultimate outcome of T-cell recognition of peptide-major histocompatibility complex (MHC) complexes is determined by the molecular context in which antigen presentation is provided. The paradigm is that, after exposure to peptides presented by steady-state dendritic cells (DCs), inhibitory signals dominate, leading to the deletion and/or functional inactivation of antigen-reactive T cells. This has been utilized in a variety of models providing peptide antigen in soluble form in the absence of adjuvant. A co-inhibitory molecule of considerable current interest is PD-1. Here we show that there is the opportunity for the PD-1/PD-L1 interaction to function in inhibiting the T-cell response during tolerance induction. Using traceable CD4(+) T-cell receptor (TCR) transgenic cells, together with a blocking antibody to disrupt PD-1 signalling, we explored the roles of PD-1 in the induction of tolerance versus a productive immune response. Intact PD-1 signalling played a role in limiting the extent of CD4(+) T-cell accumulation in response to an immunogenic stimulus. However, PD-1 signalling was not required for either the induction, or the maintenance, of peptide-induced tolerance; a conclusion underlined by successful tolerance induction in TCR transgenic cells genetically deficient for PD-1. These observations contrast with the reported requirement for PD-1 signals in CD8(+) T-cell tolerance.

摘要

T 细胞识别肽-主要组织相容性复合物(MHC)复合物的最终结果取决于抗原呈递的分子环境。这一范例是,在暴露于由稳定状态树突状细胞(DC)呈递的肽之后,抑制信号占主导地位,导致抗原反应性 T 细胞的删除和/或功能失活。这已在各种模型中得到利用,这些模型提供了无佐剂的可溶性肽抗原。目前相当关注的一种共抑制分子是 PD-1。在这里,我们表明 PD-1/PD-L1 相互作用有机会在诱导耐受期间抑制 T 细胞反应。我们使用可追踪的 CD4(+)T 细胞受体(TCR)转基因细胞,以及一种阻断抗体来破坏 PD-1 信号,探索了 PD-1 在诱导耐受与产生免疫反应中的作用。完整的 PD-1 信号在限制 CD4(+)T 细胞对免疫原性刺激的积累程度方面发挥了作用。然而,PD-1 信号对于肽诱导的耐受的诱导或维持都不是必需的;这一结论通过在 TCR 转基因细胞中成功诱导耐受得到了强调,这些细胞在 PD-1 基因缺失。这些观察结果与报告的 PD-1 信号在 CD8(+)T 细胞耐受中的作用要求形成了对比。